Refine by
Pain Treatment Articles & Analysis
51 news found
Introduction Recent marketing efforts by loupe manufacturers have claimed to offer the “only clinically proven ergonomic loupe”. This assertion focuses on the benefits of refractive loupes with deflection prism, positioning them as the exclusive solution for chronic neck and back pain in dental professionals.5 However, while refractive loupes can improve posture by using refractive ...
As the pharmaceutical industry advances, oral thin films are emerging as innovative solutions across various therapeutic areas. From cardiovascular treatments to pain management, OTF systems are playing a significant role in the future of drug delivery. ...
Patent provides protection for High Frequency Spinal Cord Stimulation with Beat Technology Vancouver, Washington – March 20, 2015 – Meagan Medical Inc., a clinical research and medical device development company focused on investigating and developing optimal ways of managing and controlling pain, announced today the issuance of a key patent related to a unique ...
Cebranopadol is a novel, dual nociceptin/orphanin FQ peptide (NOP) receptor and μ-opioid peptide (MOP) receptor agonist in development for the treatment of moderate to severe pain. Multiple clinical studies have demonstrated that cebranopadol is efficacious in different types of pain. ...
” About electroCore, Inc. electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster ...
(Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that gammaCore Sapphire™, the first and only FDA-cleared, non-invasive device to treat and prevent multiple types of headache pain via the vagus nerve, will be distributed and billed exclusively by Joerns Healthcare, LLC (Joerns) within selected managed care health systems. ...
Over the past 90 days, the Company has been focused on the optimization of its Rotigotine TDS formulation for the treatment of Parkinson’s disease, with multiple novel but related formulas under development. ...
Classification of fractional lasers From the perspective of treatment methods, fractional laser is divided into two types: peeling and no peeling. ...
Major investment to support Oncomfort’s roadmap Founded in 2017, Oncomfort is a Belgian scale-up specialized in Digital Sedation, a completely new method for relieving patients’ pain and anxiety through treatment with clinically proven sessions of therapeutic Virtual Reality. ...
Is co2 laser treatment painful Before CO2 fractional laser treatment, topical anesthesia should be applied for 40-60 minutes before treatment. During fractional CO2 laser treatment, the pain degree is mild. After treatment, local burning sensation, redness and swelling will ...
In the treatment process, choose a large spot as much as possible, so that it can reduce the scattering of light in the dermis, which can reduce the scattering, and have a faster speed and better hair removal effect. (2) Epidermal cooling Epidermal cooling protects the epidermis, allowing higher optical parameters to be applied while relieving pain during ...
Significant Drop in Mobility Due to Chronic Low Back Pain (CLBP) Demonstrated in New Mobility Index, with Highest Drop Among Those in Their 50s Treatment is Deficient with 15% Currently Taking Opioids Despite CDC Guidelines Noting Inadequate Effectiveness and Inherent Risks Only 5% Utilizing Recommended Minimally Invasive Treatment Options ...
Berkshire's receipt of this award reflects the NIH's belief in the strength of the technology behind COPA and its potential to significantly increase access to Opioid Treatment Programs for persons suffering from Opioid Use Disorder (OUD) by dramatically increasing the number of persons being allowed to utilize take home therapy," stated John Timberlake, Chief Executive Officer ...
Relievant Medsystems shared today that the company’s breakthrough chronic low back pain treatment, the Intracept Procedure, was featured on NBC’s TODAY this morning. ...
“National Spine and Pain Center’s mission is to end needless human pain and suffering by facilitating minimally invasive and non invasive approaches to pain management,” says clinical President Mark Coleman of National Spine and Pain Centers. ...
Flowonix Medical and Miratech Medical today announced the acquisition of the U.S. distribution rights to Flowonix’s state-of-the-art targeted drug delivery system for the treatment of chronic pain and spasticity by Miratech Medical in a transaction that closed on May 11th. ...
About Panag Pharma Panag Pharma Inc. is a Canadian based bio-tech company focused on the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Panag believes that pain relief should be safe, non-addictive and above all; effective. The Panag Pharma team of PhD scientists and medical doctors are among the ...
Key findings from the studies showed that while CBD and KLS-13019 were both effective in preventing the development of pain associated with CIPN, KLS-13019 was also able to reverse CIPN-related pain – while CBD proved ineffective in doing so. ...
In the past decade, pharmaceutical companies have been reluctant to re-address pain treatments following the opioids crisis. However, we see a change on the horizon. Neuropathix has designated proprietary, cannabinoid-derivative compound KLS-13019 as lead drug candidate for the treatment of neuropathic pain, a viable alternative ...
Profound is also commercializing Sonalleve®, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve® has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine ...